Exploring Clinical Study Experiences of People With Post Traumatic Stress Disorder

N/ANot Yet RecruitingNCT06146049

Power Life Sciences Inc.500 enrolled

Overview

Participation in post traumatic stress disorder observational study serves as a crucial contribution to advancing medical knowledge and refining the care provided to individuals facing similar health challenges. The primary objective centers on a meticulous examination of trial completion rates and voluntary withdrawals within this distinct patient population.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Post Traumatic Stress Disorder

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diagnosis of post traumatic stress disorder * No prior treatment for post traumatic stress disorder * Willing and able to provide informed consent. Exclusion Criteria: * Enrolled in another research study * Psychiatric or behavioral illness * Inability to provide written informed consent

Locations (1)

Power Life Sciences

San Francisco, California, United States

Outcomes

Primary Outcomes

Rate of patients who decide to enroll in a post traumatic stress disorder clinical research.

Time frame: 3 months

Number of post traumatic stress disorder study participants who remain in clinical study until completion.

Time frame: 12 months

Central Contacts

Michael B Gill

CONTACT

4159004227 bask@withpower.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.